Technological advances in the use of viral and non-viral vectors for delivering genetic and non-genetic cargos for cancer therapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Technological advances in the use of viral and non-viral vectors for delivering genetic and non-genetic cargos for cancer therapy ; day:10 ; month:6 ; year:2023 ; pages:1-20
Drug Delivery and Translational Research ; (10.6.2023), 1-20
- Creator
-
Dogbey, Dennis Makafui
Torres, Valeria Esperanza Sandoval
Fajemisin, Emmanuel
Mpondo, Liyabona
Ngwenya, Takunda
Akinrinmade, Olusiji Alex
Perriman, Adam W.
Barth, Stefan
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s13346-023-01362-3
- URN
-
urn:nbn:de:101:1-2023091910194333657533
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Dogbey, Dennis Makafui
- Torres, Valeria Esperanza Sandoval
- Fajemisin, Emmanuel
- Mpondo, Liyabona
- Ngwenya, Takunda
- Akinrinmade, Olusiji Alex
- Perriman, Adam W.
- Barth, Stefan
- SpringerLink (Online service)
Other Objects (12)
Emerging non-viral vectors for gene delivery
Non-Viral Transfection of Human T Lymphocytes
Non-viral gene therapy : gene design and delivery
Viral and non-viral systems to deliver gene therapeutics to clinical targets
Anti-metastatic effects of viral and non-viral mediated Nk4 delivery to tumours
Non‐Viral RNA Delivery During Pregnancy: Opportunities and Challenges
Characterization and optimization of the non-viral gene transfer vehicle "artificial viral particles" (AVP)
Characterization and optimization of the non-viral gene transfer vehicle "Artificial viral particles" (AVP)
Genetically Engineered Viral Vectors and Organic‐Based Non‐Viral Nanocarriers for Drug Delivery Applications
Non-viral nS/MAR DNA Vector-Based Genetic Modification of T Cells: Revolutionizing Adoptive Cell Therapies
Development of a CENH3-based and non-viral vector system
Guanidinium containing Poly(methacrylamide)s for non-viral gene delivery
Emerging non-viral vectors for gene delivery
Non-Viral Transfection of Human T Lymphocytes
Non-viral gene therapy : gene design and delivery
Viral and non-viral systems to deliver gene therapeutics to clinical targets
Anti-metastatic effects of viral and non-viral mediated Nk4 delivery to tumours
Non‐Viral RNA Delivery During Pregnancy: Opportunities and Challenges
Characterization and optimization of the non-viral gene transfer vehicle "artificial viral particles" (AVP)
Characterization and optimization of the non-viral gene transfer vehicle "Artificial viral particles" (AVP)
Genetically Engineered Viral Vectors and Organic‐Based Non‐Viral Nanocarriers for Drug Delivery Applications
Non-viral nS/MAR DNA Vector-Based Genetic Modification of T Cells: Revolutionizing Adoptive Cell Therapies
Development of a CENH3-based and non-viral vector system
Guanidinium containing Poly(methacrylamide)s for non-viral gene delivery
Emerging non-viral vectors for gene delivery
Non-Viral Transfection of Human T Lymphocytes
Non-viral gene therapy : gene design and delivery
Viral and non-viral systems to deliver gene therapeutics to clinical targets
Anti-metastatic effects of viral and non-viral mediated Nk4 delivery to tumours
Non‐Viral RNA Delivery During Pregnancy: Opportunities and Challenges
Characterization and optimization of the non-viral gene transfer vehicle "artificial viral particles" (AVP)
Characterization and optimization of the non-viral gene transfer vehicle "Artificial viral particles" (AVP)
Genetically Engineered Viral Vectors and Organic‐Based Non‐Viral Nanocarriers for Drug Delivery Applications
Non-viral nS/MAR DNA Vector-Based Genetic Modification of T Cells: Revolutionizing Adoptive Cell Therapies
Development of a CENH3-based and non-viral vector system